Goldman Sachs’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37,038
Closed -$225K 6317
2022
Q4
$225K Buy
+37,038
New +$462K ﹤0.01% 5252
2022
Q3
Sell
-1,163
Closed -$47K 6630
2022
Q2
$47K Buy
+1,163
New +$72K ﹤0.01% 6042

Other funds holding NEXI

Goldman Sachs's NEXI Position: Q1 2023 in Review

Goldman Sachs sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2023, closing a stake of 37,038 shares — an estimated $225K sold.

Goldman Sachs first reported a position in NEXI in Q2 2022 and held it in 2 quarters. The position peaked at $225K in Q4 2022. 31 funds tracked by Wall St. Rank hold NEXI as of Q1 2023.

  • Goldman Sachs reported no remaining NexImmune, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 37,038 NexImmune, Inc. Common Stock shares in Q1 2023, an estimated $225K.
  • Goldman Sachs first reported a position in NexImmune, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Goldman Sachs's NexImmune, Inc. Common Stock position peaked at $225K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.